The recent decline in gallbladder cancer mortality in Europe

被引:36
作者
Levi, F
Lucchini, F
Negri, E
La Vecchia, C
机构
[1] CHU Vaudois, Canc Epidemiol Unit, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Inst Univ Med Sociale & Prevent, Canc Registries Vaud & Neuchatel, CH-1011 Lausanne, Switzerland
[3] Mario Negri Inst Pharmacol Res, Lab Epidemiol, I-20157 Milan, Italy
[4] Univ Milan, Ist Stat Med & Biometria, I-20133 Milan, Italy
关键词
cancer; Europe; gallbladder; mortality; time; trends;
D O I
10.1097/00008469-200308000-00004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mortality from gallbladder cancer has been traditionally high in Eastern Europe, and lower in northern countries. Trends in 18 European countries, including the European Union (EU) and selected Eastern European countries, have been updated using official death certification data abstracted from the WHO database over the period 1980-1999. In the EU, age-standardized rates declined by about 30% between the late 1980s and 1999 to reach 1.8/ 100 000 for women, and by about 10% to reach 1.4/100 000 for men. In the Czech Republic and Hungary, rates for women were over 6/100000 until the early 1990s, and declined by about 25% thereafter. For males, gallbladder cancer mortality showed no consistent trend, with rates over 3/100000. Thus, a high mortality area from gallbladder cancer is still evident for both sexes in Central and Eastern Europe. The trends in mortality from gallbladder cancer are probably influenced by changes in risk factor exposure, such as diet, nutrition or tobacco, but essentially reflect more widespread and earlier adoption of cholecystectomy in the EU, since gallstones are the major risk factor for gallbladder cancer. The data also indicate the scope for further improvement of the management of gallbladder disease in Eastern Europe. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:265 / 267
页数:3
相关论文
共 28 条
[1]  
[Anonymous], 1997, TOB HLTH GLOB STAT R
[2]  
[Anonymous], 1977, INT CLASS DIS
[3]   Helicobacter pylori and the risk of benign and malignant biliary tract disease [J].
Bulajic, M ;
Maisonneuve, P ;
Schneider-Brachert, W ;
Müller, P ;
Reischl, U ;
Stimec, B ;
Lehn, N ;
Lowenfels, AB ;
Löhr, M .
CANCER, 2002, 95 (09) :1946-1953
[4]   THE ASSOCIATION BETWEEN TYPHOID CARRIAGE, TYPHOID INFECTION AND SUBSEQUENT CANCER AT A NUMBER OF SITES [J].
CAYGILL, CPJ ;
BRADDICK, M ;
HILL, MJ ;
KNOWLES, RL ;
SHARP, JCM .
EUROPEAN JOURNAL OF CANCER PREVENTION, 1995, 4 (02) :187-193
[5]   CANCER MORTALITY IN CHRONIC TYPHOID AND PARATYPHOID CARRIERS [J].
CAYGILL, CPJ ;
HILL, MJ ;
BRADDICK, M ;
SHARP, JCM .
LANCET, 1994, 343 (8889) :83-84
[6]   SMOKING AND BILIARY-TRACT CANCERS IN A COHORT OF US VETERANS [J].
CHOW, WH ;
MCLAUGHLIN, JK ;
HRUBEC, Z ;
FRAUMENI, JF .
BRITISH JOURNAL OF CANCER, 1995, 72 (06) :1556-1558
[7]   Medical progress - Biliary tract cancers [J].
de Groen, PC ;
Gores, GJ ;
LaRusso, NF ;
Gunderson, LL ;
Nagorney, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (18) :1368-1378
[8]   Trends in coronary risk factors in the WHO MONICA Project [J].
Evans, A ;
Tolonen, H ;
Hense, HW ;
Ferrario, M ;
Sans, S ;
Kuulasmaa, K .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2001, 30 :S35-S40
[9]   CONTRIBUTIONS OF OBESITY AND WEIGHT-LOSS TO GALLSTONE DISEASE [J].
EVERHART, JE .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :1029-1035
[10]  
FRAUMENI JF, 1996, CANC EPIDEMIOLOGY PR, P794